Insulin Reaches a Bottleneck in Gaza as Cold-Chain Fails

Gaza's blockade has cut off insulin—a mass-produced, globally available drug—from roughly 17,500 people, including over 1,000 children with type 1 diabetes, who need it daily to survive. The problem isn't that insulin doesn't exist; it's logistics. Restricted goods entry and collapsed refrigeration infrastructure have fractured supply chains across two and a half years. On June 3, 2026, Gaza's Ministry of Health warned that critical shortages now threaten thousands of lives.